Active in the pharmaceutical marketing for over 30 years
President of CataloniaBIO&HealthTech
CEO and Qualified Person at Kymos
Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications.
Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&HealthTech to represent the Catalonian biotech industry nationally and internationally.
Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader’s level of expertise. He publishes regularely on Kymos’ webpage, social media and in the specialized press.
Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School’s Programa Diección General (PDG)
Joan Puig de Dou2022-07-19T14:41:54+02:00May 24th, 2022|Comments Off on Pharmaprogress – Bright lights are on the horizon
In 2023, Pharmaprogress will move into a more spacious, convenient, and state-of-the-art building in the Ancona area. Luca Gramaccioni, General Site Manager of Pharmaprogress, and his team are excited about having more room soon: "In (...)
Joan Puig de Dou2022-07-19T14:44:16+02:00May 10th, 2022|Comments Off on Dissolution testing for all dosage forms
In recent months, we unfortunately had to turn down repeated requests for dissolution tests for which we would have needed the Dissolution USP 4 CE 7smart device. This was neither satisfactory for our customers nor (...)
Joan Puig de Dou2022-07-19T15:01:35+02:00March 22nd, 2022|Comments Off on Prolytic and Aeterna Zentaris – 20 years of improving human health together
For almost 20 years, Kymos’ German subsidiary Prolytic has accompanied Aeterna Zentaris in its development of pharmaceutical and diagnostic products. Katrin Dorfmeyer, Head of Chromatography, at Prolytic, and Dr. Michael Teifel, CSO at Aeterna Zentaris, (...)